ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,508Medicare Part D Prescriptions Filled, Including Refills

Rank: 64 out of 324

$665K Total Retail Price of All Prescriptions

Rank: 52 out of 324

386 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 386 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

19% of this provider’s 386 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 9,876 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LEVOTHYROXINE SODIUM 437 372 1 2
POTASSIUM CHLORIDE 420 343 2 8
FUROSEMIDE 420 357 2 7
HYDROCODONE-ACETAMINOPHEN 410 340 S3 4 5
OMEPRAZOLE 282 240 5 6
WARFARIN SODIUM 276 246 6 10
SERTRALINE HCL 263 227 7 23
SYNTHROID 258 244 8 30
SIMVASTATIN 253 218 9 1
TAMSULOSIN HCL 198 192 10 26
METFORMIN HCL 188 166 11 9
LISINOPRIL 180 154 12 3
DIGOXIN 173 162 13 40
DONEPEZIL HCL 172 141 14 25
AMLODIPINE BESYLATE 157 156 15 4
GABAPENTIN 154 126 16 13
NEXIUM 146 122 17 33
ATORVASTATIN CALCIUM 136 118 18 12
ATENOLOL 133 117 19 18
GLIMEPIRIDE 122 95 20 37
LEVOFLOXACIN 117 96 21 84
CIPROFLOXACIN HCL 107 92 22 55
LISINOPRIL-HYDROCHLOROTHIAZIDE 102 102 23 35
TRIAMTERENE-HCTZ 101 82 24 46
AZITHROMYCIN 93 78 25 48
CARVEDILOL 88 87 26 22
FENTANYL 84 84 S2 27 64
CARBIDOPA-LEVODOPA 84 83 27 80
METOPROLOL SUCCINATE 81 81 29 17
NAMENDA 78 78 30 31
RISPERIDONE 75 67 31 77
PROAIR HFA 75 59 31 50
MIRTAZAPINE 73 73 33 41
PLAVIX 73 69 33 63
METFORMIN HCL ER 72 58 35 74
ALLOPURINOL 72 59 35 27
METOPROLOL TARTRATE 70 64 37 14
PAROXETINE HCL 69 69 38 72
DICLOFENAC SODIUM 69 62 38 114
VYTORIN 66 66 40 140
LANTUS 64 44 41 39
SPIRONOLACTONE 62 58 42 47
FAMOTIDINE 62 61 42 62
CLOPIDOGREL 61 61 44 38
POLYETHYLENE GLYCOL 3350 61 61 44 49
HUMALOG MIX 75-25 60 42 46 340
FINASTERIDE 59 48 47 101
AMITRIPTYLINE HCL 59 55 R 47 66
ZOLPIDEM TARTRATE 58 47 49 20
CYCLOBENZAPRINE HCL 57 48 R 50 51
TRAZODONE HCL 55 55 51 42
HYDROCHLOROTHIAZIDE 54 46 52 11
PRAVASTATIN SODIUM 53 48 53 21
NOVOLOG 52 38 54 60
OXYBUTYNIN CHLORIDE ER 52 28 54 136
CITALOPRAM HBR 51 31 56 16
TRAMADOL HCL 50 40 57 19
MEGESTROL ACETATE 50 50 R 57 207
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.